Key result
Abstract reports no results on the representation of older maintenance dialysis patients in randomized trials.
Why the study?
Older adults have historically been under-represented in clinical trials despite distinct pharmacology, multimorbidity, and polypharmacy that may modify treatment effects.
Answers are grounded in this paper and cite their sources.
Older adults remain under-represented in dialysis RCTs; supports inclusive eligibility criteria and age-stratified analyses in future trials.
Randomized controlled trials (RCTs) provide high-quality evidence that informs the safety and efficacy of interventions. However, many RCTs lack representation of populations that may have differences in treatment effects.1 Age is an important consideration in RCTs because older adults have different pharmacology, multimorbidity, polypharmacy, and health care utilization2-4 and therefore may modify treatment effects. Older adults have also been historically under-represented in clinical trials, with many factors contributing, including participation barriers such as physical, functional, or cognitive impairments.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied Maintenance Dialysis. Representation in RCTs was evaluated. The provided abstract contains only background information regarding the representation of older patients receiving maintenance dialysis in randomized controlled trials, with no results reported.
Synapse has enriched 10 related papers. Consider them for comparative context: